Welcome to the Web Portal for the
COVAX No-Fault Compensation Program for
AMC Eligible Economies
(This site is still under construction)
Thank you for your interest in the COVAX No-Fault Compensation Program for Gavi AMC eligible economies (the “Program”). The Program is expected to be operational by 31 March 2021.
The purpose of the Program is to provide no-fault lump-sum compensation in full and final settlement of any claims to eligible individuals who suffer a serious adverse event resulting in permanent impairment or death associated with a COVID-19 vaccine procured or distributed through the COVAX Facility in any Gavi AMC eligible economy until 30 June 2022, or the administration of such a vaccine. Gavi AMC eligible economies are the 92 low- and middle-income countries and economies eligible for support via the Gavi COVAX Advance Market Commitment (AMC) of the COVAX Facility. The Program is subject to the terms of its Protocol and applicable Program forms (see below).
The independent administrator of the Program is ESIS, Inc., a wholly-owned subsidiary of Chubb Limited.
While the Program’s web portal is under construction, you may be interested to read some of the Program’s documents.
Please note that, until the Program is operational (which is expected to be on 31 March 2021):
- The Program’s documents made available through the link above are for information purposes only; and
- Applications for compensation under the Program cannot be submitted to, nor be accepted by, the Administrator until such time (but please see the “Note” below).
NOTE: Eligible individuals may apply for compensation under the Program once the Program becomes operational, even if a COVAX-distributed vaccine is administered to them before the date the Program is operational (which is expected to be 31 March 2021).
For more information about ESIS, Inc., please visit its website.